Frequently Asked Questions
COVID-19 has had a major impact on the market due to the outbreak of the COVID-19 pandemic, which increased the demand for hospital acquired disease testing.
North America accounted for the most heightened global hospital acquired disease testing market share.
Increasing cases of hospital acquired infections to drive the drug abuse testing market.
The reagent and consumables segment had a major global market share in 2022.
The hospital segment had a major share in the global market.